Article Information
PubMed
Print ISSN
Online ISSN
History
- Received September 9, 2008
- Accepted February 12, 2009
- Published online April 17, 2009.
Article Versions
- Earlier version (February 18, 2009 - 08:31).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Lin Zhou,
- Kari Schmidt,
- Frederick R. Nelson,
- Veronica Zelesky,
- Matthew D. Troutman and
- Bo Feng
- Department of Pharmaceutics, University of Washington, Seattle, Washington (L.Z.); and Department of Pharmacokinetics, Dynamics, and Drug Metabolism, Pfizer Global Research and Development, Groton, Connecticut (K.S., F.R.N., V.Z., M.D.T., B.F.)
- Address correspondence to:
Dr. Bo Feng, Pfizer Inc., Eastern Point Road, MS 8118W-131, Groton, CT 06340. E-mail: bo.feng2{at}pfizer.com
Statistics from Altmetric.com
Article usage
In this issue
The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in Mice
